CHKA and cancer: In this condition, the so-called “cholinic phenotype”, which is characterized by the overexpression of choline kinase alpha (CHKA) and increased phosphocholine (PCho) levels, supports aberrant lipid metabolic pathways typical of different cancers, including PCa.